RBC Capital analyst Brian Abrahams notes that Neurocrine’s (NBIX) CAH competitor Crinetics (CRNX) reported new phase II data from an additional cohort that were allowed to have their GC dose reduced ...
RBC Capital notes that Shift4 CEO Jared Isaacman was nominated by President Trump to be incoming NASA Administrator, which he has accepted, per a release to Shift4 employees. The release also outlines ...
RBC Capital analyst Shagun Singh raised the firm’s price target on Teleflex (TFX) to $135 from $120 and keeps a Sector Perform rating on the shares as part of a broader research note previewing 2026 ...
RBC Capital Markets late Tuesday initiated coverage on Deere (NYSE:DE) with an Outperform rating, citing the machinery maker’s leadership in precision agriculture, its growing ecosystem of connected ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results